Enregistrement :
19
de
36
(2017-12-01
à
2018-02-13)
Politique ou Programme
An opportunity for a multi-stakeholder approach in developing a solution for childhood diarrhea in low to middle income countries.
Health Canada regarding the development and implementation of an approval pathway for Subsequent Entry Biologics (SEBs), Biologics and Specialty Products.
Health Canada regarding the modernization of the Food and Drug Act (formerly Bill C-51) with respect to the development and implementation of a Progressive Licensing Framework for pharmaceuticals
Health Canada's consultation on pain medicines.
Innovation, Science and Economic Development Canada. Science and Technology strategy regarding the need for a balanced Intellectual Property regime and the important role competition plays in encouraging innovation.
International Trade regarding intellectual property provisions in bilateral and multilateral trade agreements.
Règlement
Innovation, Science and Economic Development Canada regarding the need to restore balance to the Patented Medicines (Notice of Compliance) Regulations with respect to pharmaceuticals and address operational concerns including: lack of finality to proceedings under the Regulations and lack of disincentives to discourage abuse of the Regulations.